Amping up T cells to target cancer

Cancer vaccines that harness the immune system have shown promise and some are FDA-approved, but many patients don't respond strongly. Researchers are exploring delivering vaccines with immune-stimulating molecules called cytokines to boost effectiveness. This approach aims to enhance the body's T-cell response against tumors, potentially improving outcomes for more patients.